Idebenone

艾地苯醌

Report date: 2023/03/13 17:49:01

Base Information

Drug NameIdebenone
Drug Alias Name艾迪苯醌Idebenonum羟癸醌Idebenona艾地笨 +[17] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionElectron transport chain complex proteins modulatorsReactive oxygen species modulators
TargetsReactive oxygen speciesElectron transport chain complex proteins
Therapy Area/IndicationsMotor DisordersFibrosisREM Sleep Behavior Disorder +[14] 
Global Approved IndicationsMotor DisordersOptic Atrophy, Hereditary, LeberAlzheimer Disease +[5] 
Approved Indications in ChinaMotor DisordersCerebrovascular DisordersBrain Injuries
Original Approved Country/TerritoryJapan
Original Approved Date1986/01/01
Country/TerritoryBelgiumCanadaUnited States +[15] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanthera PharmaceuticalsTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesStanford UniversityChiesi Farmaceutici SPAQilu Pharmaceutical Co Ltd
Inactive CompaniesSanthera PharmaceuticalsCentocor BvSanthera Pharmaceuticals (Deutschland) Gmbh +[7] 
Active IndicationsMotor DisordersFibrosisOptic Atrophy, Hereditary, Leber +[6] 
Inactive IndicationsREM Sleep Behavior DisorderAlzheimer DiseaseFriedreich Ataxia +[8] 

Other Information

ATC CodeN06BX13
Related LinksWikipediaDrugBankKEGG